Company Filing History:
Years Active: 2014-2015
Title: Antje Kluth Lukas: Innovator in Breast Cancer Prognosis
Introduction
Antje Kluth Lukas is a prominent inventor based in Wentorf, Germany. She has made significant contributions to the field of cancer research, particularly in the prognosis of breast cancer. With a total of 3 patents, her work focuses on innovative methods that enhance the understanding and treatment of breast tissue disorders.
Latest Patents
One of her latest patents is titled "Methods for the prognosis of breast cancer." This invention relates to modified and genomic sequences, oligonucleotides, and/or PNA-oligomers for detecting the cytosine methylation state of genomic DNA. It also includes a method for predicting disease-free survival and response to endocrine treatment in subjects with cell proliferative disorders of breast tissues. Another notable patent is "Method for providing DNA fragments derived from an archived sample." This invention outlines compositions and methods for isolating high yields of DNA from archived samples, such as paraffin-embedded and fixed-tissue biopsies. The methods are designed to ensure that the isolated genomic DNA is free of contaminants and characterized by high reproducibility and reliability.
Career Highlights
Antje Kluth Lukas is currently associated with Epigenomics AG, where she continues to advance her research in genomic technologies. Her work has been instrumental in developing methods that are both cost-effective and reliable, contributing to the field of molecular diagnostics.
Collaborations
She collaborates with notable colleagues, including Dimo Dietrich and Matthias Ballhause, to further enhance the impact of her research and innovations.
Conclusion
Antje Kluth Lukas stands out as a key figure in the field of breast cancer research, with her innovative patents paving the way for improved diagnostic methods. Her contributions are vital in the ongoing fight against cancer, showcasing the importance of innovation in medical science.